Sunil Healthcare enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast closeFY24Mar 2024
69.8—
0.10.1
66.266.2
136—
66.166.1
₹132.21—
140140
47.2%47.2%
0.49×—
1.51×—
33.25×—
−68.01×—
−9.47×—
Reference items — trailing FY values
90.290.2
4.14.1
−2.0−2.0
−14.3−14.3
−24.8−24.8
−26.3−26.3
10.510.5
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

SUNLOC₹67.90

Sunil Healthcare Limited

· Pharma & Health
₹ CrorePeersBPLPHARMAJENBURPHKPLMAKERSLNOVARTINDPARNAXLABSGRLSHUKRAPHARMcap ₹69.8 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
Current
last close
Market Capitalization—69.8
- Cash, Equiv & ST Investments0.10.1
+ Total Debt66.266.2
Enterprise Value—135.9
Net Debt (memo)66.166.1
EV per Share—132.21
Total Capital140.2140.2
Total Debt/Total Capital47.1947.19
Total Debt/EV—0.49
EV/Sales—1.51
EV/EBITDA—33.25
EV/EBIT—-68.01
EV/Operating Cash Flow—-9.47
Reference Items — Trailing FY Values
Sales90.290.2
EBITDA4.14.1
EBIT-2.0-2.0
Operating Cash Flow-14.3-14.3
Free Cash Flow-24.8-24.8
FCFF (free cash flow to the firm)-26.3-26.3
Capital Expenditure10.510.5
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.